• Nenhum resultado encontrado

Diagnóstico do caso da edição anterior

N/A
N/A
Protected

Academic year: 2017

Share "Diagnóstico do caso da edição anterior"

Copied!
2
0
0

Texto

(1)

Radiological Diagnosis

A female patient with history of chronic muscle weakness who has been experiencing fever, dyspnea on exertion, and dry cough for 3 weeks.

J Bras Pneumol. 2007;33(4):493-494

Diagnosis of the case presented in the previous edition

J Bras Pneumol. 2007;33(3):362

Polymyositis associated with bronchiolitis

obliterans organizing pneumonia

Comments

Clinical and laboratory findings confirmed the diagnosis of anti-Jo-1 antibody positive polymyo-sitis, and the transbronchial biopsy correlated with bronchiolitis obliterans organizing pneumonia (BOOP).

In the illustrative images of this case, this diag-nostic hypothesis can be formulated based on the findings of muscle calcification (left intercostal),

which correlate with chronic polymyositis, associa-ted with the presence of consolidations and peri-pheral bilateral ground-glass opacities which, in this context, suggest BOOP.

(2)

494 Diagnóstico do caso da edição anterior

References

1. Tazelaar HD, Viggiano RW, Pickersgill J, Colby TV. Interstitial lung disease in polymyositis and dermatomyositis. Clinical features and prognosis as correlated with histologic findings. Am Rev Respir Dis. 1990;141(3):727-33.

2. Nascimento AP, Abreu AC, Diógenes AM, Neto ML, Gonçalves RC, Borba EF. Bronquiolite obliterante com pneumonia em organização (BOOP) precedendo o diagnóstico de polimio-site: relato de caso e revisão de literatura. Rev Bras Reumatol. 2000;40(3):149-152.

4. Kim EA, Lee KS, Johkoh T, Kim TS, Suh GY, Kwon OJ et al. Interstitial lung diseases associated with collagen vas-cular diseases: radiologic and histopathologic findings. Radiographics. 2002;22 Spec No:S151-S165.

5. Akira M, Hara H, Sakatani M. Interstitial lung disease in association with polymyositis-dermatomyositis: long-term follow-up CT evaluation in seven patients. Radiology. 1999;210(2):333-8.

J Bras Pneumol. 2007;33(4):493-494

Interstitial lung disease as primary involvement can be detected in 5 to 30% of the patients with polymyositis, and BOOP, usual interstitial pneumo-nia, nonspecific interstitial pneumopneumo-nia, and diffuse alveolar disease are the most common patterns. The identification of BOOP accompanied by dermato-polymyositis is made simultaneously or after the diagnosis of myositis in most cases, and it rarely precedes the muscle profile.

Dany Jasinowodolinski, Gustavo de Souza Portes Meirelles,

Nestor L Müller

Fleury Center for Diagnostic Medicine, São Paulo, Brazil; Universidade Federal de São Paulo – UNIFESP, Federal University of São Paulo - São Paulo, Brazil; University of British Columbia – Vancouver, BC, Canada

Readers correctly diagnosing the case presented in the May/June 2007 issue:

Eric Loures de Souza – Universidade Federal Fluminense – Niterói - RJ

Elza Maria Rezende de Almeida – Centro de Saúde da Policia Militar – Macapá - AP

Bruno Hochhegger – Santa Casa de Porto Alegre – Porto Alegre - RS

Jaquelina Sonoe Ota Arakaki – Universidade Federal de São Paulo – São Paulo - SP

Ricardo Domingos Delduque – Hospital Padre Albino – Catanduva - SP

Referências

Documentos relacionados

Serial evaluation of high-resolution computed tomography findings in patients with idiopathic pulmonary fibrosis in usual

Drug-induced interstitial lung disease (acute lung opacity) can have a number of histopathologic manifestations, including DAD, eosinophilic pneu- monia, organizing

Cyclophosphamide and low-dose prednisone therapy in patients with systemic sclerosis (scleroderma) with interstitial lung disease. Harrison NK, Myers AR, Corrin B, Soosay G, Dewar

Table 1 - Characteristics of 17 patients with combined pulmonary fibrosis and emphysema treated at the Interstitial Lung Disease Outpatient Clinic of the University of São

Drug-induced interstitial lung disease (acute lung opacity) can have a number of histopathologic manifestations, including DAD, eosinophilic pneu- monia, organizing

Cyclophosphamide and low-dose prednisone therapy in patients with systemic sclerosis (scleroderma) with interstitial lung disease. Harrison NK, Myers AR, Corrin B, Soosay G, Dewar

proposed that the term LDCTD be used in order to characterize patients with any known pattern of ILD (usual interstitial pneumonia— UIP—NSIP, lymphocytic interstitial pneumonia,

Table 2 - Pulmonary function test results at diagnosis in 17 patients with combined pulmonary fibrosis and emphysema treated at the Interstitial Lung Disease Outpatient Clinic